Invention Grant
US08632787B2 Methods using immunomodulatory compounds for treatment of certain leukemias
有权
使用免疫调节化合物治疗某些白血病的方法
- Patent Title: Methods using immunomodulatory compounds for treatment of certain leukemias
- Patent Title (中): 使用免疫调节化合物治疗某些白血病的方法
-
Application No.: US13310543Application Date: 2011-12-02
-
Publication No.: US08632787B2Publication Date: 2014-01-21
- Inventor: Jerome B. Zeldis
- Applicant: Jerome B. Zeldis
- Applicant Address: US NJ Summit
- Assignee: Celgene Corporation
- Current Assignee: Celgene Corporation
- Current Assignee Address: US NJ Summit
- Agency: Jones Day
- Main IPC: A61K45/00
- IPC: A61K45/00 ; A61K47/00
Abstract:
Methods of treating, preventing or managing leukemias are disclosed. The methods encompass the administration of an immunomodulatory compound of the invention. The invention further relates to methods of treatment using an immunomodulatory compound with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy. Pharmaceutical compositions and single unit dosage forms suitable for use in the methods of the invention are also disclosed.
Public/Granted literature
- US20120135042A1 Methods Using Immunomodulatory Compounds For Treatment of Certain Leukemias Public/Granted day:2012-05-31
Information query
